Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

  1. Rossello, X.
  2. Raposeiras-Roubin, S.
  3. Latini, R.
  4. Dominguez-Rodriguez, A.
  5. Barrabés, J.A.
  6. Sánchez, P.L.
  7. Anguita, M.
  8. Fernández-Vázquez, F.
  9. Pascual-Figal, D.
  10. De la Torre Hernandez, J.M.
  11. Ferraro, S.
  12. Vetrano, A.
  13. Pérez-Rivera, J.A.
  14. Prada-Delgado, O.
  15. Escalera, N.
  16. Staszewsky, L.
  17. Pizarro, G.
  18. Agüero, J.
  19. Pocock, S.
  20. Ottani, F.
  21. Fuster, V.
  22. Ibáñez, B.
Aldizkaria:
European heart journal. Cardiovascular pharmacotherapy

ISSN: 2055-6845

Argitalpen urtea: 2022

Alea: 8

Zenbakia: 3

Orrialdeak: 291-301

Mota: Artikulua

DOI: 10.1093/EHJCVP/PVAB060 GOOGLE SCHOLAR